- Report
- May 2025
- 50 Pages
Global
From €2424EUR$2,650USD£2,063GBP
- Report
- March 2025
- 220 Pages
Global
From €3992EUR$4,365USD£3,398GBP
€4436EUR$4,850USD£3,776GBP
- Report
- February 2025
- 132 Pages
Global
From €3992EUR$4,365USD£3,398GBP
€4436EUR$4,850USD£3,776GBP
- Report
- January 2025
- 191 Pages
Global
From €4568EUR$4,995USD£3,889GBP
- Report
- June 2024
- 200 Pages
Global
From €7271EUR$7,950USD£6,189GBP
- Report
- May 2024
- 193 Pages
Global
From €4568EUR$4,995USD£3,889GBP
- Report
- August 2024
- 160 Pages
United States
From €3292EUR$3,599USD£2,802GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3539EUR$3,869USD£3,012GBP
- Report
- June 2024
- 140 Pages
Africa, Middle East
From €3539EUR$3,869USD£3,012GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3539EUR$3,869USD£3,012GBP
- Report
- June 2024
- 140 Pages
Europe
From €3539EUR$3,869USD£3,012GBP
- Drug Pipelines
- April 2025
- 60 Pages
Europe
From €1829EUR$2,000USD£1,557GBP
- Report
- October 2024
- 136 Pages
North America
From €3658EUR$4,000USD£3,114GBP
- Report
- August 2024
- 128 Pages
North America
From €1372EUR$1,500USD£1,168GBP
- Report
- August 2024
- 142 Pages
Africa, Middle East
From €1372EUR$1,500USD£1,168GBP
- Report
- August 2024
- 141 Pages
Europe
From €1372EUR$1,500USD£1,168GBP
- Report
- August 2024
- 142 Pages
Asia Pacific
From €1372EUR$1,500USD£1,168GBP
From €300EUR$351USD£264GBP
From €300EUR$351USD£264GBP
- Report
- October 2021
- 154 Pages
Global
From €5076EUR$5,550USD£4,321GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more